PubRank

Albert C Ludolph

Author PubWeight™ 164.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 2009 4.38
2 X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 2002 2.21
3 Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol 2008 2.11
4 Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2010 2.00
5 Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol 2008 1.78
6 Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic? J Neurol Neurosurg Psychiatry 2010 1.68
7 Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 2005 1.55
8 Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 2010 1.47
9 Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 2011 1.45
10 Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005 1.42
11 Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005 1.40
12 The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One 2010 1.32
13 Amyotrophic lateral sclerosis--a model of corticofugal axonal spread. Nat Rev Neurol 2013 1.29
14 The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 2009 1.26
15 IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One 2009 1.25
16 Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp 2010 1.23
17 Riluzole in Huntington's disease: a 3-year, randomized controlled study. Ann Neurol 2007 1.21
18 Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale. PLoS One 2011 1.15
19 Alternative trial design in amyotrophic lateral sclerosis saves time and patients. Amyotroph Lateral Scler 2007 1.15
20 The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 2011 1.12
21 Neuroectodermally converted human mesenchymal stromal cells provide cytoprotective effects on neural stem cells and inhibit their glial differentiation. Cytotherapy 2010 1.10
22 Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue. Aging Cell 2010 1.09
23 A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One 2012 1.09
24 A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet 2010 1.09
25 Histopathological analysis of skeletal muscle in patients with Parkinson's disease and 'dropped head'/'bent spine' syndrome. Parkinsonism Relat Disord 2009 1.08
26 Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A 2005 1.06
27 NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosis. Mol Cancer Ther 2011 1.06
28 Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). J Neurol Sci 2009 1.05
29 Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. Exp Neurol 2008 1.05
30 Phosphoinositide 3-kinases upregulate system xc(-) via eukaryotic initiation factor 2α and activating transcription factor 4 - A pathway active in glioblastomas and epilepsy. Antioxid Redox Signal 2014 1.05
31 Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry 2006 1.04
32 Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology 2005 1.01
33 Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008 1.01
34 Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. Acta Neuropathol 2014 1.00
35 MRI-based functional neuroimaging in ALS: an update. Amyotroph Lateral Scler 2009 0.99
36 A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 2012 0.98
37 CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis. PLoS One 2012 0.98
38 Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Rev Mol Diagn 2008 0.98
39 Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice. Ann Neurol 2006 0.97
40 NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis. Hum Mol Genet 2012 0.97
41 Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol Dis 2013 0.96
42 PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet 2013 0.96
43 TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 2014 0.96
44 Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. Amyotroph Lateral Scler 2012 0.96
45 Biochemical markers in CSF of ALS patients. Curr Med Chem 2008 0.95
46 Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS). Neurochem Res 2008 0.95
47 Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 2007 0.95
48 Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 2003 0.95
49 Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis 2013 0.94
50 Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response. Acta Neuropathol 2011 0.93
51 A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol Aging 2012 0.93
52 Emotional responding in amyotrophic lateral sclerosis. J Neurol 2005 0.92
53 Effects of mitochondrial dysfunction on the immunological properties of microglia. J Neuroinflammation 2010 0.92
54 Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neurosci Lett 2003 0.92
55 Diffusion tensor imaging and tractwise fractional anisotropy statistics: quantitative analysis in white matter pathology. Biomed Eng Online 2007 0.92
56 A large genome scan for rare CNVs in amyotrophic lateral sclerosis. Hum Mol Genet 2010 0.92
57 Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) 2013 0.91
58 Intersubject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques. Magn Reson Imaging 2008 0.91
59 Quantification of human body fat tissue percentage by MRI. NMR Biomed 2011 0.91
60 Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler 2008 0.91
61 High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener 2013 0.90
62 Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 2004 0.90
63 In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp Neurol 2006 0.90
64 Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation. Acta Neuropathol 2015 0.90
65 Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization. Ann Neurol 2014 0.90
66 Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol 2010 0.90
67 Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett 2009 0.89
68 The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener 2014 0.89
69 Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun 2013 0.89
70 Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2010 0.89
71 Emotional adjustment in amyotrophic lateral sclerosis (ALS). J Neurol 2011 0.89
72 Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study. Parkinsonism Relat Disord 2009 0.88
73 H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging 2012 0.87
74 Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol 2005 0.86
75 Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis. PLoS One 2011 0.86
76 Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord 2007 0.86
77 Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. J Neurol 2009 0.86
78 Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol 2007 0.86
79 Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms. BMC Neurol 2012 0.86
80 On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea). Mov Disord 2005 0.85
81 Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener 2014 0.85
82 Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 2007 0.85
83 Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues. Biochim Biophys Acta 2010 0.85
84 Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport 2004 0.85
85 Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord 2006 0.84
86 Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson's disease: a resting-state FMRI and videooculographic study. Brain Connect 2013 0.84
87 A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry 2011 0.84
88 MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci 2010 0.84
89 Can lesions to the motor cortex induce amyotrophic lateral sclerosis? J Neurol 2013 0.84
90 Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci 2005 0.84
91 Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol 2009 0.84
92 Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function. Neurorehabil Neural Repair 2007 0.84
93 C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol 2014 0.83
94 Deep brain stimulation and behavioural changes: is comedication the most important factor? Neurodegener Dis 2011 0.83
95 Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol 2013 0.83
96 Developmental and functional nature of human iPSC derived motoneurons. Stem Cell Rev 2013 0.83
97 Connective tissue disorders in dissections of the carotid or vertebral arteries. J Clin Neurosci 2008 0.83
98 Only subtle cognitive deficits in non-bulbar amyotrophic lateral sclerosis patients. J Neurol 2005 0.83
99 The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases. Neurogenetics 2012 0.83
100 Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia. BMC Neurol 2013 0.83
101 The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain Behav 2012 0.83
102 Frequency of a tau genotype in amyotrophic lateral sclerosis. J Neurol Sci 2005 0.82
103 Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS. Eur J Neurosci 2007 0.82
104 Fumaric acid esters stimulate astrocytic VEGF expression through HIF-1α and Nrf2. PLoS One 2013 0.82
105 Do eye movement impairments in patients with small vessel cerebrovascular disease depend on lesion load or on cognitive deficits? A video-oculographic and MRI study. J Neurol 2014 0.82
106 The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes. J Neural Transm (Vienna) 2012 0.81
107 Serum Vitamin D Concentrations and Cognitive Function in a Population-Based Study among Older Adults in South Germany. J Alzheimers Dis 2015 0.81
108 Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy. Clin Res Cardiol 2011 0.81
109 Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship? Muscle Nerve 2008 0.81
110 Complementary image analysis of diffusion tensor imaging and 3-dimensional t1-weighted imaging: white matter analysis in amyotrophic lateral sclerosis. J Neuroimaging 2011 0.81
111 Parkinson's disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis. J Neurol 2012 0.81
112 Primary progressive aphasia accompanied by environmental sound agnosia: a neuropsychological, MRI and PET study. Psychiatry Res 2006 0.81
113 Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging. Mov Disord 2008 0.81
114 Neurotransplantation in mice: the concorde-like position ensures minimal cell leakage and widespread distribution of cells transplanted into the cisterna magna. Neurosci Lett 2007 0.81
115 Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage Clin 2013 0.81
116 Motor neuron disease: urgently needed-biomarkers for amyotrophic lateral sclerosis. Nat Rev Neurol 2011 0.81
117 MR-pathologic comparison of the upper spinal cord in different motor neuron diseases. Eur Neurol 2005 0.81
118 Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid. J Neuroimmunol 2009 0.81
119 Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord 2004 0.81
120 Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid. J Neurosci Res 2003 0.81
121 Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol 2015 0.81
122 Live and let die: existential decision processes in a fatal disease. J Neurol 2014 0.81
123 Chemical hypoxia facilitates alternative splicing of EAAT2 in presymptomatic APP23 transgenic mice. Neurochem Res 2007 0.81
124 Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved? Cephalalgia 2010 0.80
125 Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2003 0.80
126 Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci Lett 2007 0.80
127 Signs of impaired selective attention in patients with amyotrophic lateral sclerosis. J Neurol 2008 0.80
128 Directional colour encoding of the human thalamus by diffusion tensor imaging. Neurosci Lett 2008 0.80
129 Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS One 2013 0.80
130 Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study. J Neurol 2015 0.80
131 Erythropoietin in cerebrospinal fluid: age-related reference values and relevance in neurological disease. Neurochem Res 2007 0.80
132 Efficient processing of Alzheimer's disease amyloid-Beta peptides by neuroectodermally converted mesenchymal stem cells. Stem Cells Dev 2010 0.79
133 Fast diffusion tensor magnetic resonance imaging of the mouse brain at ultrahigh-field: aiming at cohort studies. PLoS One 2012 0.79
134 Additional resources and the default mode network: Evidence of increased connectivity and decreased white matter integrity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2014 0.79
135 Micronutrients supplementation and nutritional status in cognitively impaired elderly persons: a two-month open label pilot study. Nutr J 2013 0.79
136 A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study. BMC Neurol 2012 0.79
137 Different regional brain volume loss in pure and complicated hereditary spastic paraparesis: a voxel-based morphometric study. Amyotroph Lateral Scler 2007 0.79
138 Rate of change in early Huntington's disease: a clinicometric analysis. Mov Disord 2011 0.79
139 Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany. J Alzheimers Dis 2012 0.79
140 Neuroimaging of motor neuron diseases. Ther Adv Neurol Disord 2012 0.78
141 Camptocormia in Parkinson's disease: a review of the literature. Neurodegener Dis 2011 0.78
142 The cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosum. PLoS One 2012 0.78
143 Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosis. Neurochem Res 2010 0.78
144 Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot. Acta Neuropathol Commun 2014 0.78
145 A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol Neurodegener 2011 0.78
146 Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease. Biomed Eng Online 2014 0.78
147 Diffusion tensor magnetic resonance imaging of the brain in APP transgenic mice: a cohort study. PLoS One 2013 0.78
148 Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration. J Proteome Res 2014 0.78
149 Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J Neurol 2015 0.78
150 Perihematomal Diffusion Restriction in Intracerebral Hemorrhage Depends on Hematoma Volume, But Does Not Predict Outcome. Cerebrovasc Dis 2016 0.78
151 Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicentre studies in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2015 0.77
152 Identification of candidate genes for sporadic amyotrophic lateral sclerosis by array comparative genomic hybridization. Amyotroph Lateral Scler 2009 0.77
153 Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm. Med Hypotheses 2009 0.77
154 Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 2006 0.77
155 Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II. Muscle Nerve 2014 0.77
156 Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD. Neurobiol Aging 2010 0.77
157 Tubulin-binding cofactor B is a direct interaction partner of the dynactin subunit p150(Glued). Cell Tissue Res 2012 0.77
158 Mice with mutation in dynein heavy chain 1 do not share the same tau expression pattern with mice with SOD1-related motor neuron disease. Neurochem Res 2011 0.77
159 The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families. J Neurol 2010 0.77
160 The proteoglycan-dystrophin complex in genetic cardiomyopathies--lessons from three siblings with limb-girdle muscular dystrophy-2I (LGMD-2I). Clin Res Cardiol 2011 0.77
161 Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases. Neurodegener Dis 2013 0.77
162 Age-related changes in tau expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 2007 0.77
163 Cardiac involvement in juvenile overlap-myositis detected by cardiac magnetic resonance imaging. Int J Cardiol 2010 0.77
164 Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry. BMC Neurol 2006 0.76
165 Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis. BMC Neurol 2012 0.76
166 Chromosomal translocation t(18;21)(q23;q22.1) indicates novel susceptibility loci for frontotemporal dementia with ALS. Ann Neurol 2004 0.76
167 MRI allows for longitudinal quantitative analysis of body fat composition in rats: an analysis of sibutramine-associated changes at the group level. Magn Reson Imaging 2013 0.76
168 Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. Neuroreport 2003 0.76
169 Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes. Mov Disord 2010 0.76
170 Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism. Neurodegener Dis 2017 0.76
171 CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees. Neurobiol Dis 2002 0.76
172 Ifosfamide encephalopathy presenting with asterixis. J Neurol Sci 2002 0.75
173 Hereditary motor neuropathies and motor neuron diseases: which is which. Amyotroph Lateral Scler Other Motor Neuron Disord 2002 0.75
174 Spastin related hereditary spastic paraplegia with dysplastic corpus callosum. J Neurol Sci 2005 0.75
175 Complicated hereditary spastic paraplegia with thin corpus callosum: variation of phenotypic expression over time. J Neurol 2004 0.75
176 Full-length PGC-1α salvages the phenotype of a mouse model of human neuropathy through mitochondrial proliferation. Hum Mol Genet 2013 0.75
177 Polyneuropathy in type 1 and type 2 diabetes: do we need different examinations? Diabetes Metab Res Rev 2010 0.75
178 Correspondence (reply): In Reply. Dtsch Arztebl Int 2008 0.75
179 Frontal corpus callosum alterations in progressive supranuclear palsy but not in Parkinson's disease. Neurodegener Dis 2014 0.75
180 Motor protein diseases of the nervous system. Amyotroph Lateral Scler Other Motor Neuron Disord 2005 0.75
181 Amygdala size reduction is associated with memory deficits in complicated hereditary spastic paraparesis: an MRI study. Eur Neurol 2010 0.75
182 [Amyotrophic lateral sclerosis]. Med Monatsschr Pharm 2014 0.75
183 Seroprevalence of Borna disease virus antibodies is not increased in patients with amyotrophic lateral sclerosis. J Neurol 2002 0.75
184 Erratum to: Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2015 0.75
185 Classification of phenotype characteristics in adult-onset spinal muscular atrophy. Eur Neurol 2007 0.75